Andrew Reason

Andrew Reason has over 25 years of experience in the biopharmaceutical industry. Andrew is currently the CEO and MD of BioPharmaspec, a contract research organization specializing in structural characterization and physico-chemical analysis of biopharmaceuticals. Prior to their current role, Andrew was a Visiting Professor at the University of Warwick and a consultant at Acumentia Consulting Ltd, where they provided expertise in food, beverage, nutrition, and healthcare solutions. Andrew also held various management positions at SGS, including UK Business Manager Life Science Services and Managing Director of M-Scan Limited and M-Scan GmbH. Andrew began their career as a Post-Doctoral Research Assistant at the University of London.

Andrew Reason obtained a B.Sc (Hons) in Biochemistry from the University of Wales, College Swansea from 1985 to 1988. Andrew then pursued higher education and earned a Ph.D in Biochemistry from the University of London (Imperial College) between 1989 and 1992.